Digestive & Intestinal Remedies (Pharmacies) - GCC

GCC

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$222.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.36%, resulting in a market volume of US$237.60m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$3.68 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in GCC is experiencing steady growth due to increasing customer preferences for over-the-counter remedies, rising awareness about digestive health, and the presence of local special circumstances. Customer preferences in the GCC region are shifting towards self-medication and over-the-counter remedies for digestive and intestinal issues. Consumers are becoming more proactive in managing their health and are seeking convenient and accessible solutions. This preference is driven by factors such as busy lifestyles, the desire for quick relief, and the increasing availability of a wide range of over-the-counter products in pharmacies. Additionally, customers in the GCC region have a strong preference for natural and herbal remedies, leading to the growth of products that cater to this demand. Trends in the market indicate a growing awareness about digestive health and the importance of maintaining a healthy gut. Consumers are increasingly seeking products that promote digestive wellness, such as probiotics and digestive enzymes. This trend is driven by factors such as changing dietary habits, stress, and the prevalence of digestive disorders. The market is also witnessing a rise in the demand for products that address specific digestive issues, such as acid reflux, constipation, and irritable bowel syndrome. Manufacturers are responding to these trends by introducing innovative products that target these specific needs. Local special circumstances in the GCC region contribute to the development of the Digestive & Intestinal Remedies market. The high prevalence of certain lifestyle factors, such as sedentary lifestyles, unhealthy diets, and stress, contribute to the increased incidence of digestive issues among the population. Additionally, the region has a high prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers, which further drive the demand for digestive remedies. The hot climate in the GCC region also affects digestive health, as it can lead to dehydration and imbalances in the gut microbiota. Underlying macroeconomic factors also play a role in the growth of the Digestive & Intestinal Remedies market in the GCC region. The region has a growing population, which translates to a larger consumer base for healthcare products. Additionally, increasing disposable incomes and improved healthcare infrastructure contribute to the accessibility and affordability of digestive remedies. The GCC region also attracts medical tourism, with individuals seeking specialized healthcare services, including digestive treatments. This further boosts the demand for digestive remedies in the region. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in the GCC region is developing due to customer preferences for over-the-counter remedies, increasing awareness about digestive health, the presence of local special circumstances, and underlying macroeconomic factors. As consumers become more proactive in managing their health and seek convenient solutions, the market is witnessing a shift towards self-medication and a preference for natural remedies. The growing awareness about digestive health and the prevalence of digestive issues in the region further drive the demand for digestive remedies. The GCC region's unique circumstances, such as lifestyle factors and the hot climate, contribute to the market's growth. Additionally, the region's growing population, increasing disposable incomes, and improved healthcare infrastructure support the development of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.